Online citations, reference lists, and bibliographies.

Dengue Virus Life Cycle: Viral And Host Factors Modulating Infectivity

Izabela A. Rodenhuis-Zybert, J. Wilschut, J. M. Smit
Published 2010 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Dengue virus (DENV 1-4) represents a major emerging arthropod-borne pathogen. All four DENV serotypes are prevalent in the (sub) tropical regions of the world and infect 50–100 million individuals annually. Whereas the majority of DENV infections proceed asymptomatically or result in self-limited dengue fever, an increasing number of patients present more severe manifestations, such as dengue hemorrhagic fever and dengue shock syndrome. In this review we will give an overview of the infectious life cycle of DENV and will discuss the viral and host factors that are important in controlling DENV infection.
This paper references
10.4049/jimmunol.0801974
A Protective Role for Dengue Virus-Specific CD8+ T Cells 1
Lauren E. Yauch (2009)
10.1016/j.smim.2006.12.004
TLR signaling.
S. Akira (2006)
10.4269/ajtmh.1988.38.411
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.
S. C. Kliks (1988)
10.1016/j.chom.2009.04.001
Pathogenesis of flavivirus infections: using and abusing the host cell.
M. Fernandez-Garcia (2009)
10.1099/0022-1317-75-5-1183
Glycosylation mutants of dengue virus NS1 protein.
M. Pryor (1994)
10.4269/ajtmh.1988.38.172
A prospective study of dengue infections in Bangkok.
D. Burke (1988)
10.1111/j.1600-065X.2008.00678.x
Understanding the contribution of cellular immunity to dengue disease pathogenesis
A. Mathew (2008)
10.1006/VIRO.2000.0524
Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells.
Y. L. Lin (2000)
10.1111/j.1462-5822.2008.01277.x
Human TLR3 recognizes dengue virus and modulates viral replication in vitro
Yi-Ting Tsai (2009)
10.1016/0264-410X(94)90206-2
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.
B. A. Fonseca (1994)
10.4269/AJTMH.2001.65.427
Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein.
M. Pryor (2001)
10.1002/JMV.20786
Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70
A. Cabrera-Hernández (2007)
10.1016/S0140-6736(99)04015-5
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever
D. Watts (1999)
10.1073/pnas.0832193100
A ligand-binding pocket in the dengue virus envelope glycoprotein
Y. Modis (2003)
10.1016/J.IJID.2006.02.012
Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore.
A. Ong (2007)
10.1186/1471-2180-6-85
The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells
R. F. Mercado-Curiel (2006)
10.1086/343813
High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.
D. Libraty (2002)
10.1016/0042-6822(90)90099-D
Acidotropic amines inhibit proteolytic processing of flavivirus prM protein.
V. Randolph (1990)
10.1084/jem.170.3.763
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity
I. Kurane (1989)
10.1038/nri2038
Cooperation of Toll-like receptor signals in innate immune defence
G. Trinchieri (2007)
Flow Cytometric Determination for Dengue Virus-Infected Cells: Its Application for Antibody-Dependent Enhancement Study
K. Huang (2005)
10.1016/J.VIROL.2004.12.036
Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein.
D. E. Purdy (2005)
10.1007/s11262-008-0211-7
Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein
S. Tajima (2008)
10.1128/JVI.77.12.7143-7149.2003
Flavivirus Capsid Is a Dimeric Alpha-Helical Protein
C. T. Jones (2003)
10.1016/S0166-0934(01)00346-9
A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
A. R. Hunt (2001)
10.1038/nsmb.1456
Viral membrane fusion
S. Harrison (2008)
Sudiro TM (2005) Genetic variations and relationship among dengue virus type 3 strains isolated from patients with mild or severe form of dengue disease in Indonesia and Thailand
M Raekiansyah (2005)
10.1006/VIRO.1997.8504
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas.
R. Rico-Hesse (1997)
10.1099/0022-1317-68-3-853
Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.
J. Schlesinger (1987)
10.1128/JVI.78.22.12647-12656.2004
Serotype-Specific Entry of Dengue Virus into Liver Cells: Identification of the 37-Kilodalton/67-Kilodalton High-Affinity Laminin Receptor as a Dengue Virus Serotype 1 Receptor
C. Thepparit (2004)
10.1371/journal.pone.0001192
High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection
T. Dong (2007)
Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.
G. Kourí (1989)
10.3201/EID0401.980111
Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.
G. Kourí (1998)
10.4049/jimmunol.168.11.5959
T Cell Responses to an HLA-B*07-Restricted Epitope on the Dengue NS3 Protein Correlate with Disease Severity1
Iva Zivna (2002)
10.1128/JVI.73.4.2650-2657.1999
Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism
Y. Chen (1999)
10.1034/J.1399-0039.2002.600405.X
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.
H. A. Stephens (2002)
10.1126/science.1153264
Structure of the Immature Dengue Virus at Low pH Primes Proteolytic Maturation
I-Mei Yu (2008)
10.1128/JVI.78.19.10543-10555.2004
Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway
J. J. Chu (2004)
10.1007/BF01314031
NS 1 gene sequences from eight dengue-2 viruses and their evolutionary relationships with other dengue-2 viruses
J. Blok (2005)
10.4269/ajtmh.1981.30.1100
Histocompatibility antigens and dengue hemorrhagic fever.
P. Chiewsilp (1981)
10.1038/ng1550
A variant in the CD209 promoter is associated with severity of dengue disease
A. Sakuntabhai (2005)
10.1111/j.1348-0421.1984.tb00732.x
Development of a new cell system for the infectivity assay of dengue viruses: plaque formation and virus growth of prototype and wild-type dengue virus strains in a newly established cell line, GK.
Masaru Nawa (1984)
10.1371/journal.ppat.1000060
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
S. Nelson (2008)
10.1086/519170
Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.
C. Simmons (2007)
10.1038/nm887
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
J. Mongkolsapaya (2003)
10.1074/jbc.M504337200
Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN)-mediated Enhancement of Dengue Virus Infection Is Independent of DC-SIGN Internalization Signals*
Pierre-Yves Lozach (2005)
10.1128/JVI.69.9.5816-5820.1995
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.
S. L. Allison (1995)
10.1128/JVI.73.6.4738-4747.1999
Dengue Virus Structural Differences That Correlate with Pathogenesis
K. Leitmeyer (1999)
10.1086/383043
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization.
K. Jessie (2004)
10.1099/vir.0.2008/001594-0
Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines.
I. Umareddy (2008)
10.1016/J.CHOM.2007.03.002
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
T. Pierson (2007)
10.1128/JVI.01732-06
Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein
T. Oliphant (2006)
10.1128/JVI.01125-06
Crystal Structure of the West Nile Virus Envelope Glycoprotein
G. Nybakken (2006)
10.1128/JVI.78.6.2701-2710.2004
Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical
S. Shresta (2004)
10.1111/j.1462-5822.2009.01345.x
Alternative infectious entry pathways for dengue virus serotypes into mammalian cells
E. G. Acosta (2009)
10.1006/VIRO.1998.9200
Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
J. Roehrig (1998)
10.4269/AJTMH.2005.72.631
Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti.
A. Molina-Cruz (2005)
10.1016/S0042-6822(02)00028-4
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
G. Chang (2003)
10.4269/ajtmh.1987.36.427
Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.
B. Kaufman (1987)
10.1111/j.1574-695X.2008.00420.x
Vascular endothelium: the battlefield of dengue viruses
A. Basu (2008)
10.1099/0022-1317-69-8-2101
Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
E. Henchal (1988)
10.1159/000100567
Susceptibility of Mouse Macrophage J774 to Dengue Virus Infection
M. M. Moreno-Altamirano (2007)
10.1016/S0092-8674(02)00660-8
Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion
R. Kuhn (2002)
10.1098/rspb.2009.0331
Immunological serotype interactions and their effect on the epidemiological pattern of dengue
M. Recker (2009)
10.1016/j.cell.2005.11.042
Cryo-EM Reconstruction of Dengue Virus in Complex with the Carbohydrate Recognition Domain of DC-SIGN
E. Pokidysheva (2006)
10.1086/380762
Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles.
Thành Hưng Nguyễn (2004)
10.1016/J.VIROL.2007.05.007
Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes.
J. Bryant (2007)
Sequences of terminal noncoding regions from four dengue-2 viruses isolated from patients exhibiting different disease
MN Mangada (1997)
10.1016/0042-6822(91)90809-P
Dengue virus premembrane and membrane proteins elicit a protective immune response.
M. Bray (1991)
10.4269/ajtmh.1985.34.162
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.
E. Henchal (1985)
10.4269/ajtmh.1977.26.1199
Replication of dengue-2 virus in Aedes albopictus mosquitoes. An electron microscopic study.
S. Sriurairatna (1977)
10.1093/clind/16.2.295
Nutritional status of children with dengue hemorrhagic fever.
U. Thisyakorn (1993)
10.1073/pnas.2335168100
Inhibition of interferon signaling by dengue virus
J. L. Muñoz-Jordán (2003)
10.1086/500949
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.
Panisadee Avirutnan (2006)
Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease.
A. Nisalak (1970)
10.1128/JVI.78.5.2367-2381.2004
Alterations of pr-M Cleavage and Virus Export in pr-M Junction Chimeric Dengue Viruses
P. Keelapang (2004)
10.1128/JVI.79.2.1223-1231.2005
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Y. Modis (2005)
DNA
SM Costa (2006)
10.1038/cr.2008.46
Regulation of interferon production and innate antiviral immunity through translational control of IRF-7
A. Erickson (2008)
10.1016/J.VIROL.2003.08.012
Translation efficiency determines differences in cellular infection among dengue virus type 2 strains.
D. Edgil (2003)
10.1128/JVI.01257-06
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
Karen J. Clyde (2006)
10.1371/journal.ppat.1000453
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
Bruce S. Thompson (2009)
10.1016/S1074-7613(00)80340-4
Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.
P. Aichele (1997)
10.1128/MCB.9.11.5062
cDNA structures and regulation of two interferon-induced human Mx proteins.
M. Aebi (1989)
10.1016/J.BBRC.2007.08.137
Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1.
T. Kurosu (2007)
10.1016/S0198-8859(02)00682-1
HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever.
Curtis LaFleur (2002)
10.1038/77553
Human skin Langerhans cells are targets of dengue virus infection
S. Wu (2000)
10.4049/jimmunol.176.6.3821
T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?1
J. Mongkolsapaya (2006)
10.1099/VIR.0.18723-0
Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus.
Sigrid Elshuber (2003)
Cytokine patterns during dengue shock syndrome.
C. Suharti (2003)
10.1078/0171-2985-00058
Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever.
E. Azeredo (2001)
10.1099/0022-1317-74-2-175
Processing of the dengue virus type 2 proteins prM and C-prM.
J. Murray (1993)
10.1016/J.VIROL.2007.05.042
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gregory D. Gromowski (2007)
10.1128/jvi.64.7.3370-3375.1990
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein.
J. Pavlović (1990)
against the non - structural 1 protein ( NS 1 ) of dengue 2 virus
EA Henchal (1988)
10.1371/journal.pntd.0000215
Differential Gene Expression Changes in Children with Severe Dengue Virus Infections
M. D. de Kruif (2008)
10.1007/s00705-003-0263-x
Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2
S. Jindadamrongwech (2003)
10.4049/jimmunol.176.5.2825
The Dual-Specific Binding of Dengue Virus and Target Cells for the Antibody-Dependent Enhancement of Dengue Virus Infection1
K. Huang (2006)
10.1016/J.STR.2004.06.019
Conformational changes of the flavivirus E glycoprotein.
Y. Zhang (2004)
10.1111/J.1574-695X.2003.TB00646.X
Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.
A. Atrasheuskaya (2003)
10.1038/NM0897-866
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Y. Chen (1997)
10.1002/0470058005.CH12
T cell responses and dengue haemorrhagic fever.
G. Screaton (2006)
10.1016/j.virusres.2009.05.016
Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability.
R. Takhampunya (2009)
10.1128/JVI.71.6.4226-4232.1997
Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.
R. Anderson (1997)
10.1016/0092-8674(78)90329-X
Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts
M. Clemens (1978)
10.1128/JVI.02484-07
Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection
K. Boonnak (2008)
10.1371/journal.ppat.0040017
The Mannose Receptor Mediates Dengue Virus Infection of Macrophages
J. Miller (2008)
10.1128/JVI.74.11.4957-4966.2000
Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons
M. Diamond (2000)
10.1038/nature03956
Structural basis of West Nile virus neutralization by a therapeutic antibody
G. Nybakken (2005)
10.1128/JVI.73.7.6104-6110.1999
Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion
M. Flamand (1999)
10.1371/journal.ppat.1000718
Immature Dengue Virus: A Veiled Pathogen?
Izabela A. Rodenhuis-Zybert (2010)
10.1128/JVI.71.11.8475-8481.1997
Proteolytic activation of tick-borne encephalitis virus by furin.
K. Stadler (1997)
10.1111/J.1348-0421.2000.TB02480.X
Severity-related molecular differences among nineteen strains of dengue type 2 viruses.
B. Pandey (2000)
10.1016/j.clim.2009.01.015
Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak.
R. Chen (2009)
10.1016/S0065-3527(03)59003-0
Flavivirus structure and membrane fusion.
F. Heinz (2003)
10.1128/JVI.00316-08
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
Chih-yun Lai (2008)
10.1038/nrmicro1067
A structural perspective of the flavivirus life cycle
S. Mukhopadhyay (2005)
10.1016/j.meegid.2009.02.003
Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease.
S. Weaver (2009)
10.1099/vir.0.2008/002535-0
Functional importance of dengue virus maturation: infectious properties of immature virions.
I. Zybert (2008)
10.1007/s00705-004-0430-8
Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: Construction and characterization of mutant viruses
M. Crabtree (2004)
10.1002/JMV.1890450417
Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2
R. He (1995)
10.1053/JHEP.2000.18713
Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes
P. Hilgard (2000)
10.1023/A:1007914520454
Sequences of Terminal Non-Coding Regions from Four Dengue-2 Viruses Isolated from Patients Exhibiting Different Disease Severities
M. N. Mangada (2004)
10.1084/jem.20021840
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
B. Tassaneetrithep (2003)
10.1186/1471-2180-2-9
Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.
M. J. Cardosa (2002)
10.1590/S1020-49892002000400003
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks.
M. Guzmán (2002)
10.4269/ajtmh.1989.41.576
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
B. Kaufman (1989)
10.1128/JVI.79.9.5414-5420.2005
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
M. Jones (2005)
10.1099/0022-1317-79-11-2631
Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins.
M. Pryor (1998)
10.1128/JVI.79.8.4557-4567.2005
Heat Shock Protein 90 and Heat Shock Protein 70 Are Components of Dengue Virus Receptor Complex in Human Cells
J. Reyes-del Valle (2005)
10.1002/0470058005.CH3
Molecular biology of flaviviruses.
E. Harris (2006)
10.4049/jimmunol.175.4.2676
Altered Cytokine Responses of Dengue-Specific CD4+ T Cells to Heterologous Serotypes 1
Maloy M Mangada (2005)
10.1038/emboj.2009.245
Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody
Mickaël V Cherrier (2009)
10.1038/sj.embor.embor866
Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses
Erika Navarro-Sánchez (2003)
10.1099/VIR.0.80283-0
Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly.
M. Pryor (2004)
10.1086/324320
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
H. Loke (2001)
10.1128/JVI.00062-06
Murine Model for Dengue Virus-Induced Lethal Disease with IncreasedVascular Permeability
S. Shresta (2006)
10.1016/S1473-3099(01)00171-2
Dengue: an update.
M. Guzmán (2002)
10.1097/00005072-196410000-00010
HEMORRHAGES INTO PERIPHERAL NERVES IN ASSOCIATION WITH LEUKEMIA.
A. Brun (1964)
10.1099/VIR.0.83028-0
Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus.
O. Lisova (2007)
Determinants of dengue virus infection
J Mongkolsapaya (2006)
- free protein synthesis by pppA 2 0 p 5 0 A 2 0 p 5 0 A : a novel oligonucleotide synthesized by interferon - treated L cell extracts
J Pavlovic (1990)
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
R. Littaua (1990)
Dengue Viruses and Mononuclear Phagocytes
S. Halstead (2003)
Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak.
A. Chakravarti (2006)
10.1128/JVI.00037-07
Structure of Immature West Nile Virus
Y. Zhang (2007)
10.4269/AJTMH.2002.67.102
Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes.
H. Loke (2002)
10.1093/emboj/cdg270
Structures of immature flavivirus particles
Y. Zhang (2003)
10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.0.CO;2-G
Elevated plasma interleukin‐10 levels in acute dengue correlate with disease severity
S. Green (1999)
10.4269/AJTMH.2002.67.76
A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein.
María Yazi Mendoza (2002)
10.4269/AJTMH.2001.65.180
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.
S. Halstead (2001)
10.1128/JVI.02210-06
Rab 5 Is Required for the Cellular Entry of Dengue and West Nile Viruses
M. N. Krishnan (2007)
10.1089/104454901317094981
The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein.
C. Chang (2001)
10.1099/0022-1317-74-12-2653
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus.
V. Vorndam (1993)
10.1016/S0065-3527(03)60011-4
Neutralization and antibody-dependent enhancement of dengue viruses.
S. Halstead (2003)
10.1099/vir.0.83357-0
Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis.
E. G. Acosta (2008)
10.1016/0035-9203(87)90041-1
Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).
J. Bravo (1987)
Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic.
Min-Sheng Lee (2006)
10.1002/(SICI)1096-9071(199903)57:3<322::AID-JMV17>3.0.CO;2-5
Retrospective study of western blot profiles in immune sera of natural dengue virus infections
S. Se-Thoe (1999)
10.4269/AJTMH.1997.56.566
Risk factors in dengue shock syndrome.
S. Thein (1997)
10.1038/375291A0
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
F. Rey (1995)
10.1016/j.virol.2008.10.022
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus.
P. Sun (2009)
10.1128/JVI.73.3.2547-2551.1999
PrM- and Cell-Binding Domains of the Dengue Virus E Protein
S. Wang (1999)
10.1006/VIRO.2001.1232
Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus.
R. Germi (2002)
10.1016/S0264-410X(01)00446-7
Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine.
E. Konishi (2002)
10.1016/j.imbio.2008.11.008
Role of antibodies in controlling dengue virus infection.
Hilde M. van der Schaar (2009)
Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.
P. Avirutnan (1998)
10.1172/JCI115457
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
I. Kurane (1991)
10.1099/vir.0.006874-0
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.
R. Rajamanonmani (2009)
10.1038/nature07013
CLEC5A is critical for dengue-virus-induced lethal disease
Szu-Ting Chen (2008)
10.1016/S1201-9712(02)90072-X
Effect of age on outcome of secondary dengue 2 infections.
M. Guzmán (2002)
Flaviviruses. In: Knipe DM, Howley PM (eds) Fields virology
DS Burke (2001)
Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic
GP Kouri (1989)
Molecular mechanisms of interferon action: interferon-mediated phosphorylation of ribosome-associated protein P1 and protein synthesis initiation factor eIF-2.
C. Samuel (1981)
10.1006/VIRO.1998.9093
Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities.
M. N. Mangada (1998)
10.1111/j.1365-2249.2006.02996.x
NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease
E. Azeredo (2006)
10.1099/VIR.0.82537-0
Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells.
T. Chareonsirisuthigul (2007)
10.3201/EID1502.080926
Severe Dengue Epidemics in Sri Lanka, 2003–2006
N. Kanakaratne (2009)
10.1099/0022-1317-69-2-445
Production of interferon alpha by dengue virus-infected human monocytes.
I. Kurane (1988)
10.1186/1471-2180-7-9
Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes
M. I. Salazar (2006)
10.1016/J.HUMIMM.2007.03.001
HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection.
B. Sierra (2007)
10.1038/nrmicro1326
Virus membrane-fusion proteins: more than one way to make a hairpin
M. Kielian (2006)
10.3201/eid0812.020170
Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored
S. Halstead (2002)
10.1016/J.VIROL.2003.09.048
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice.
S. Shresta (2004)
10.1038/nature02165
Structure of the dengue virus envelope protein after membrane fusion
Y. Modis (2004)
10.1073/PNAS.0305892101
Solution structure of dengue virus capsid protein reveals another fold.
Lixin Ma (2004)
10.1128/JVI.73.1.783-786.1999
New Mouse Model for Dengue Virus Vaccine Testing
A. Johnson (1999)
Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.
L. Ho (2005)
Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients.
D. Hober (1993)
10.3201/eid0907.030038
Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus
W. Messer (2003)
10.1128/JVI.76.8.3784-3790.2002
Membrane Interactions of the Tick-Borne Encephalitis Virus Fusion Protein E at Low pH
K. Stiasny (2002)
10.1111/j.1749-6632.2009.05055.x
T lymphocyte responses to heterologous secondary dengue virus infections.
A. Rothman (2009)
10.1128/JVI.02188-08
NS5 of Dengue Virus Mediates STAT2 Binding and Degradation
J. Ashour (2009)
10.3844/AJIDSP.2008.60.68
Anti-Prm Antibody as an Autoantibody in Dengue Virus Infection
Kao Jean Huang (2008)
10.1016/S0966-842X(01)02288-0
Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.
D. Gubler (2002)
10.1371/journal.ppat.1000244
Dissecting the Cell Entry Pathway of Dengue Virus by Single-Particle Tracking in Living Cells
H. M. van der Schaar (2008)
10.1186/1471-2180-8-118
A dengue receptor as possible genetic marker of vector competence in Aedes aegypti
R. F. Mercado-Curiel (2008)
10.1016/J.VACCINE.2005.08.022
DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus.
S. M. Costa (2006)
inhibition of
(2005)
10.1128/JVI.00300-07
Characterization of the Early Events in Dengue Virus Cell Entry by Biochemical Assays and Single-Virus Tracking
H. M. van der Schaar (2007)
10.1111/J.1399-0039.2004.00304.X
TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients.
M. Fernandez-Mestre (2004)
10.1371/journal.pone.0001557
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency
Yuan-Chang Chao (2008)
10.1002/1096-9071(200010)62:2<224::AID-JMV14>3.0.CO;2-C
Dengue NS1‐specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever
P. Shu (2000)
10.4049/jimmunol.175.6.3946
Critical Roles for Both STAT1-Dependent and STAT1-Independent Pathways in the Control of Primary Dengue Virus Infection in Mice1
S. Shresta (2005)
10.1038/nsb990
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
W. Zhang (2003)
10.1002/0470058005.CH2
Dengue/dengue haemorrhagic fever: history and current status.
D. Gubler (2006)
10.1128/JVI.01180-08
Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction
Jiraphan Junjhon (2008)
10.1186/1471-2334-8-86
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity
F. Bozza (2008)
10.1038/265739a0
Antibody-enhanced dengue virus infection in primate leukocytes
S. Halstead (1977)
Molecular mechanisms of interferon action: interferon-mediated phosphorylation of ribosome-associated protein P1 and protein synthesis initiation factor eIF-2.
Samuel Ce (1981)
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.
S. Halstead (1970)
10.1128/JVI.79.2.853-859.2005
Selection for Virulent Dengue Viruses Occurs in Humans and Mosquitoes
Raymond Cologna (2005)
10.1128/JVI.74.15.7146-7150.2000
Release of Vasoactive Cytokines by Antibody-Enhanced Dengue Virus Infection of a Human Mast Cell/Basophil Line
C. King (2000)
10.1590/S0074-02762004000600003
Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population.
José Roberto Polizel (2004)
10.1016/S0065-3527(03)61006-7
Dengue epidemiology: virus epidemiology, ecology, and emergence.
S. Thomas (2003)
Genetic variations and relationship among dengue virus type 3 strains isolated from patients with mild or severe form of dengue disease in Indonesia and Thailand.
Muhareva Raekiansyah (2005)
10.1007/978-3-642-02215-9_7
Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis.
A. Rothman (2010)
10.4269/AJTMH.1993.48.324
Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients
D. Hober (1993)



This paper is referenced by
État des lieux de la dengue d'importation au CHU de Bordeaux entre 2014-2015 : moyens de prévention du risque de dengue en France métropolitaine, rôle du pharmacien d'officine dans la lutte anti-vectorielle
M. Dupouy (2016)
Apoptin : oncogenic transformation & tumor-selective apoptosis
R. M. E. Zimmerman (2011)
Nanostructured labels for enhanced paper based immunoassays
E. M. Linares (2013)
Descripción de un modelo de infección in vitro con virus dengue empleando células mononucleares humanas de sangre periférica
Félix Giovanni Delgado Tiria (2014)
10.1146/annurev-immunol-031210-101315
Immune response to dengue virus and prospects for a vaccine.
B. Murphy (2011)
Medicinal plants used in dengue treatment: An overview
Ravi Kumar Pigili (2014)
10.1186/s12906-017-1562-1
Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections
Cecilia Gómez-Calderón (2017)
SOCS 1 / SOCS 3 Expression and Virus Replication of DENV 2 and HSV-1 in Cytokine-Polarized Subsets of RAW 264 . 7 Macrophages
N. R. Cheemarla (2016)
10.1371/journal.pntd.0007202
Virulence difference of five type I dengue viruses and the intrinsic molecular mechanism
Chunling Zou (2019)
Anti-dengue Medicinal Plants: A Mini Review.
S. Swain (2013)
10.1101/2020.09.14.295915
Fusion and fission events regulate endosome maturation and viral escape
Mario Castro (2020)
Dengue Virus Infection of Human Microvascular Endothelial Cells
M. Obeysekera (2016)
10.1111/tra.12469
Beyond attachment: Roles of DC‐SIGN in dengue virus infection
P. Liu (2017)
Assessing the Lack Awareness and Dangers of Dengue in Rural Punjab Pakistan
Muhammad Pervaiz Iqbal (2014)
10.3390/vaccines7040203
Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention
Joshua Blight (2019)
10.1038/s41598-020-59388-3
Sensitive Detection of Dengue Virus Type 2 E-Proteins Signals Using Self-Assembled Monolayers/Reduced Graphene Oxide-PAMAM Dendrimer Thin Film-SPR Optical Sensor
N. Omar (2020)
10.1016/J.IMU.2016.06.001
Identification of bioflavonoid as fusion inhibitor of dengue virus using molecular docking approach
A. Mir (2016)
10.3389/fcimb.2020.00375
Senescence in Monocytes Facilitates Dengue Virus Infection by Increasing Infectivity
Tzu-Han Hsieh (2020)
10.1371/journal.pone.0112474
Galectin-1 Exerts Inhibitory Effects during DENV-1 Infection
K. Toledo (2014)
10.1080/10158782.2012.11441511
A traveller returning to South Africa with fever and haemorrhagic rash
George M Nyale (2012)
Host-Virus Interactions in Dengue Infection indicate Targets for Detection and Therapeutic Interventions
S. Sanyal (2012)
Dengue virus type 4 evolution and genomics: A bioinformatic approach
S. Pal (2014)
10.1186/s12879-018-2976-1
Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border
Marlen Yelitza Carrillo-Hernández (2018)
10.4103/0974-7168.194322
An observation on direct changes in Aedes albopictus midgut cells by Rhus tox 6C in relation to dengue virus infection
Moonmoon Sinha (2016)
10.1101/412577
Integrative analysis of Zika virus genome RNA structure reveals critical determinants of viral infectivity
Pan Li (2018)
Phenotypic and genotypic analysis for quality control of Wolbachia-infected Aedes aegypti in a dengue biocontrol program
H. Yeap (2014)
10.1186/s12859-018-2313-0
Application of whole genome data for in silico evaluation of primers and probes routinely employed for the detection of viral species by RT-qPCR using dengue virus as a case study
K. Vanneste (2018)
10.1016/B978-0-12-819400-3.00016-8
Dengue Virus
A. Murugesan (2020)
10.1016/B978-0-12-809633-8.12245-9
Surface Plasmon Resonance: A Boon for Viral Diagnostics
P. Singh (2017)
Review on Dengue Fever : An Emerging Public Health Issue
Smit Shah (2018)
10.1007/s00705-018-3757-2
Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions
P. M. Villegas (2018)
10.1039/c4lc01127a
A stacking flow immunoassay for the detection of dengue-specific immunoglobulins in salivary fluid.
Y. Zhang (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar